These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36698317)

  • 21. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.
    Decosterd LA; Rochat B; Pesse B; Mercier T; Tissot F; Widmer N; Bille J; Calandra T; Zanolari B; Marchetti O
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5303-15. PubMed ID: 20855739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice.
    Yoon SJ; Lee K; Oh J; Woo HI; Lee SY
    Clin Biochem; 2019 Aug; 70():14-17. PubMed ID: 31175859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.
    Miao Q; Tang JT; van Gelder T; Li YM; Bai YJ; Zou YG; Wang LL; Shi YY
    Medicine (Baltimore); 2019 Jan; 98(3):e14137. PubMed ID: 30653146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of linezolid and voriconazole serum concentrations using liquid chromatography-tandem mass spectrometry.
    Lu Q; He X; Fang J; Shi K; Hu F; Bian X; Wang X
    J Pharm Biomed Anal; 2022 Apr; 212():114659. PubMed ID: 35182831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of Voriconazole in Peritoneal Fluid of Critically Ill Patients.
    Lin XB; Hu XG; Tang ZX; Guo PH; Liu XM; Liang T; Xia YZ; Lui KY; Chen P; Tang KJ; Chen X; Cai CJ
    Antimicrob Agents Chemother; 2023 May; 67(5):e0172122. PubMed ID: 37022169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers.
    Cojutti P; Candoni A; Forghieri F; Isola M; Zannier ME; Bigliardi S; Luppi M; Fanin R; Pea F
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):474-9. PubMed ID: 26572687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
    Pascual A; Nieth V; Calandra T; Bille J; Bolay S; Decosterd LA; Buclin T; Majcherczyk PA; Sanglard D; Marchetti O
    Antimicrob Agents Chemother; 2007 Jan; 51(1):137-43. PubMed ID: 17088483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children.
    Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A
    Br J Clin Pharmacol; 2018 Jan; 84(1):197-203. PubMed ID: 28805964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CYP2C19 Phenotype and Drug-Drug Interactions on Voriconazole Concentration in Pediatric Patients.
    Tian X; Zhang C; Qin Z; Wang D; Yang J; Zhang X
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0020721. PubMed ID: 34152823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous quantitation of five triazole anti-fungal agents by paper spray-mass spectrometry.
    Skaggs CL; Ren GJ; Elgierari ETM; Sturmer LR; Shi RZ; Manicke NE; Kirkpatrick LM
    Clin Chem Lab Med; 2020 Apr; 58(5):836-846. PubMed ID: 31926066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Application Study of Voriconazole and Its Metabolites Concentration Monitoring in Allogeneic Hematopoietic Stem Cell Transplantation Patients].
    Wang HC; Wang L; Li M; Shi L; Sun HH; Liu HX; Ou HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):945-951. PubMed ID: 38926993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of the Triazole Antifungal Compounds Voriconazole and Posaconazole in Human Serum or Plasma Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
    Molinelli AR; Rose CH
    Methods Mol Biol; 2016; 1383():39-47. PubMed ID: 26660172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a New Method for Simultaneous Quantitation of Plasma Concentrations of Voriconazole and Voriconazole
    Yamamoto T; Ishida M; Kodama N; Saiki Y; Fujiyoshi M; Shimada M
    Yonago Acta Med; 2023 Aug; 66(3):365-374. PubMed ID: 37621974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring and safety of voriconazole in elderly patients.
    Cheng L; Xiang R; Liu F; Li Y; Chen H; Yao P; Sun F; Xia P
    Int Immunopharmacol; 2020 Jan; 78():106078. PubMed ID: 31830620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we predict the influence of inflammation on voriconazole exposure? An overview.
    Boglione-Kerrien C; Zerrouki S; Le Bot A; Camus C; Marchand T; Bellissant E; Tron C; Verdier MC; Gangneux JP; Lemaitre F
    J Antimicrob Chemother; 2023 Nov; 78(11):2630-2636. PubMed ID: 37796931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
    Vanstraelen K; Maertens J; Augustijns P; Lagrou K; de Loor H; Mols R; Annaert P; Malfroot A; Spriet I
    Clin Pharmacokinet; 2015 Nov; 54(11):1151-60. PubMed ID: 25910879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.
    Huang FR; Zhou C; Zhang XY; Shen Y; Zhang HW; Wang YQ; Sun LN
    Xenobiotica; 2021 Oct; 51(10):1199-1206. PubMed ID: 34402388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.
    Job KM; Olson J; Stockmann C; Constance JE; Enioutina EY; Rower JE; Linakis MW; Balch AH; Yu T; Liu X; Thorell EA; Sherwin CM
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):731-46. PubMed ID: 27355512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of Voriconazole Concentrations in Serum by GC-MS.
    Smith A; Leung-Pineda V
    J Clin Lab Anal; 2016 Sep; 30(5):411-7. PubMed ID: 26351082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.